Case Reports
22 November 2021
Vol. 73 No. 3 (2021)
https://doi.org/10.4081/reumatismo.2021.1445

Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
COVID-19, COVID-19 vaccine, herpes zoster, rheumatology.
7251
Views
951
Downloads

Authors

B. Maranini
beatrice.maranini@edu.unife.it
https://orcid.org/0000-0002-7313-3520
Rheumatology Unit, Department of Medical Sciences, University of Ferrara, Italy.
G. Ciancio
Rheumatology Unit, Department of Medical Sciences, University of Ferrara, Italy.
R. Cultrera
Infectious Diseases, Department of Translational Medicine, University of Ferrara, Italy.
M. Govoni
Rheumatology Unit, Department of Medical Sciences, University of Ferrara, Italy.

Since the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) pandemic outbreak, vaccines gained a growing role. Possible vaccine-related side effects range from minor local events to more prominent systemic manifestations up to anaphylactic reactions. A heterogeneous spectrum of cutaneous reactions has been reported, ranging from local injection site reactions to urticarial and morbilliform eruptions, pernio/chilblains and zoster flares. Here, we describe a case of varicella zoster virus reactivation following mRNA coronavirus 2019 vaccine and discuss the available literature upon the topic published so far.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020; 383(27). [Epub ahead of print].
Cohen JI. Clinical practice: Herpes zoster. N Engl J Med. 2013; 369: 255-63. DOI: https://doi.org/10.1056/NEJMcp1302674
Walter R, Hartmann K, Fleisch F, et al. Reactivation of herpesvirus infections after vaccinations? Lancet (London, England). 1999; 353: 810. DOI: https://doi.org/10.1016/S0140-6736(99)00623-6
Bostan E, Yalici-Armagan B. Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence? J Cosmet Dermatol. 2021; 20: 1566-7. DOI: https://doi.org/10.1111/jocd.14035
Eid E, Abdullah L, Kurban M, Abbas O. Herpes zoster emergence following mRNA COVID-19 vaccine. J Med Virol. 2021; 93: 5231-2. DOI: https://doi.org/10.1002/jmv.27036
McMahon DE, Amerson A, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021; 85: 46-55. DOI: https://doi.org/10.1016/j.jaad.2021.03.092
Furer V, Zisman D, Kibari A, et al. Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology (Oxford, England). 2021. [Epub ahead of print]. DOI: https://doi.org/10.1093/rheumatology/keab702
Zhang C, Maruggi G, Shan H, Li J. Advances in mRNA vaccines for infectious diseases. Front Immunol. 2019; 10: 594. DOI: https://doi.org/10.3389/fimmu.2019.00594
Furer V, Rondaan C, Heijstek M, et al. Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD Open. 2019; 5: e001041. DOI: https://doi.org/10.1136/rmdopen-2019-001041

How to Cite



Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis. (2021). Reumatismo, 73(3). https://doi.org/10.4081/reumatismo.2021.1445

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.